YOLFTbeta
ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc

ANIP · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

71.44USD+0.38 (+0.53%)

Price History

Full chart

Market Stats

Previous Close71.06
Open70.54
Day Range70.37 – 72.00
52-Week Range69.58 – 97.00
Volume383.90K
Market Cap1.70B
P/E (TTM)16.19
Forward P/E7.12
EPS4.57
Dividend Yield0.00%
Beta0.45
50-Day Avg76.01
200-Day Avg78.76

About

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Nikhil Lalwani
  • Employees970
  • Headquarters210 Main Street West, Baudette, MN, United States, 56623, USA
  • Websitehttps://www.anipharmaceuticals.com

Leadership

  • Mr. Nikhil LalwaniPresident, CEO & Director · b. 1978
  • Mr. Stephen P. CareySenior VP of Finance & CFO · b. 1971
  • Ms. Meredith W. Cook J.D.Senior VP, General Counsel & Corporate Secretary · b. 1974
  • Mr. Christopher K. MutzSenior VP & Head of Rare Disease · b. 1972
  • Mr. Ori GutwergSenior Vice President of Generics · b. 1975
  • Mr. Muthusamy Shanmugam MS R.Ph.Head of R&D and COO of New Jersey Operations · b. 1968
  • Ms. Irina Rivkind KofflerVice President of Investor Relations
  • Ms. Elizabeth Powell J.D.Chief Compliance Officer & Head of Legal of Rare Disease
  • Mr. Chad GassertSenior Vice President of Corporate Development & Strategy · b. 1976
  • Ms. Krista L. DavisSenior VP & Chief Human Resources Officer · b. 1973

Financials

Income Statement

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue123.06K121.75M2.83M65.49K77.89K258.35K14.44M493.05K3.78M1.26M2.47M435.16K2.30M30.08M55.97M76.32M128.62M176.84M201.58M206.55M208.47M216.14M316.38M486.82M614.38M883.37M
Growth (%)--100.00%+100.00%+87369200.00%+62.18%-97.69%+18.92%+231.70%+5488.76%-96.59%+666.82%-66.73%+96.67%-82.41%+428.71%+1207.49%+86.06%+36.36%+68.53%+37.49%+13.99%+2.47%+0.93%+3.67%+46.38%+53.87%+26.20%+43.78%
Cost of Revenue---24.29K---------268.75K50.00K9.17M9.97M11.47M12.69M48.78M79.03M73.02M63.15M87.16M100.61M138.78M181.51M250.21M432.73M
Gross Profit123.06K124.29K1.75M2.83M65.49K77.89K258.35K14.44M493.05K3.78M1.26M2.21M385.16K-6.87M20.11M44.50M63.63M79.84M97.81M128.55M143.39M121.32M115.53M177.60M305.30M364.17M450.64M
Gross Margin100.00%100.00%1214600.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%89.14%88.51%-298.44%66.84%79.50%83.37%62.07%55.31%63.77%69.42%58.19%53.45%56.13%62.71%59.27%51.01%
Operating Expense2.78M1.60M3.69M4.53M6.64M6.11M12.34M9.56M11.00M9.17M21.79M39.68M45.81M51.31M16.31M19.21M24.49M30.93M59.76M69.48M93.19M127.04M137.33M155.32M212.88M258.33M363.58M369.41M
Operating Income-2.66M-1.60M-3.66M-2.79M-3.81M-6.05M-12.27M-9.30M3.44M-8.68M-18.01M-38.43M-43.61M-50.93M-23.17M898.00K20.01M32.70M20.08M28.33M35.36M16.35M-16.02M-39.79M-35.28M46.97M584.00K81.23M
Operating Margin-2161.05%-160494100.00%-183245550.00%-159.43%-134.47%-9231.29%-15749.47%-3600.61%23.82%-1760.34%-476.45%-3054.36%-1762.50%-11703.01%-1007.14%2.99%35.74%42.84%15.61%16.02%17.54%7.92%-7.68%-18.41%-11.15%9.65%0.10%9.20%
EBITDA-2.52M-1.51M-3.31M-2.68M-3.72M-5.95M-11.91M-9.55M3.56M-7.49M-17.38M-47.24M-45.34M-50.78M-27.23M7.51M24.04M39.64M56.31M57.16M69.10M60.73M28.13M3.12M25.04M106.60M63.12M207.27M
EBITDA Margin-2047.48%-151397600.00%-165720250.00%-153.10%-131.22%-9089.41%-15297.05%-3696.56%24.64%-1520.04%-459.74%-3755.28%-1832.49%-11668.97%-1183.65%24.96%42.96%51.94%43.78%32.32%34.28%29.40%13.49%1.44%7.91%21.90%10.27%23.46%
Net Income-2.66M-1.41M-3.44M-2.61M-3.81M-5.96M-12.02M-9.65M2.79M-7.58M-17.43M-47.53M-46.20M-51.61M-27.72M301.00K28.75M15.38M3.93M-1.08M15.49M6.09M-22.55M-42.60M-47.90M18.78M-18.52M78.34M
Net Income Margin-2161.05%-140625900.00%-171859750.00%-149.44%-134.47%-9099.08%-15427.94%-3735.63%19.33%-1538.26%-460.88%-3777.88%-1867.09%-11859.66%-1204.73%1.00%51.36%20.14%3.06%-0.61%7.69%2.95%-10.82%-19.71%-15.14%3.86%-3.01%8.87%
R&D1.40M660.59K1.89M2.14M4.79M3.69M9.16M6.41M3.86M4.75M15.79M13.68M39.71M44.18M16.89M1.71M2.68M2.87M2.91M9.07M15.39M19.81M16.00M11.37M22.32M34.29M44.58M51.66M
R&D as % of Total Revenue1137.75%66058800.00%94391600.00%122.58%168.92%5636.27%11763.91%2480.76%26.70%963.65%417.63%1087.44%1604.76%10153.11%734.06%5.69%4.78%3.77%2.26%5.13%7.63%9.59%7.68%5.26%7.05%7.04%7.26%5.85%
Interest Expense00000000000147.03K688.08K681.57K348.02K467.00K787.00K11.01M11.33M12.04M14.76M12.97M9.45M11.92M28.05M26.94M17.60M20.06M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%11.69%27.81%156.63%15.13%1.55%1.41%14.42%8.81%6.81%7.32%6.28%4.53%5.52%8.87%5.53%2.87%2.27%

Balance Sheet

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.45M5.78M3.07M4.98M5.88M9.57M17.83M9.57M22.37M31.24M17.68M36.44M44.77M62.38M38.77M44.50M263.71M285.26M322.86M412.14M430.60M456.79M461.19M771.60M760.09M904.42M1.28B1.44B
Total Liabilities817.91K329.12K941.26K927.76K1.26M881.21K1.91M2.76M4.30M1.52M3.85M20.61M25.62M24.56M10.59M3.54M123.92M125.18M153.22M237.38M233.34M244.00M265.49M412.86M421.55M446.82M855.17M899.65M
Total Equity2.63M5.45M2.13M4.05M4.62M8.68M15.92M6.82M18.07M29.73M13.83M15.83M19.15M37.82M28.18M40.96M139.78M160.08M169.65M174.76M197.26M212.79M195.70M358.74M338.54M457.60M428.53M540.72M
Cash2.84M5.27M2.61M4.50M4.88M9.13M1.17M310.64K7.65M15.65M11.76M29.86M38.16M57.23M34.79M11.11M169.04M154.68M27.36M31.14M43.01M62.33M7.86M100.30M48.23M221.12M144.86M285.58M
Total Debt--500.00K--------16.68M18.55M17.34M7.88M-110.69M113.43M120.64M201.51M183.01M185.75M185.69M287.37M286.52M285.67M624.09M325.19M
Net Debt-2.84M-5.27M-2.11M-4.50M-4.88M-9.13M-1.17M-310.64K-7.65M-15.65M-11.76M-13.18M-19.61M-39.89M-26.91M-11.11M-58.35M-41.26M93.28M170.36M140.01M123.42M177.82M187.07M238.29M64.55M479.23M39.61M

Cash Flow

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.04M-1.79M-3.21M-1.82M-3.96M-5.52M-10.44M-8.30M-5.00M739.99K-15.54M-18.43M-40.10M-47.87M-25.28M-5.48M22.03M17.26M27.47M39.42M67.07M45.63M15.27M3.32M-31.20M118.96M64.02M185.22M
Investing Cash Flow-124.98K-4.22K-43.24K-86.73K-38.99K-8.87K-16.20M7.24M4.96M-11.24M11.33M2.86M-60.37K-719.92K-619.15K20.27M-35.75M-32.68M-154.06M-107.99M-27.38M-27.55M-68.32M-105.48M-15.74M-18.51M-404.72M-34.32M
Financing Cash Flow4.26M4.23M588.04K3.80M4.38M9.78M18.68M197.77K7.38M18.49M319.38K33.67M48.45M67.66M3.47M-3.69M171.65M1.07M-729.00K72.36M-27.82M1.25M-1.44M194.59M-5.13M67.44M264.94M-9.94M
Capital Expenditure124.98K4.22K43.24K86.73K38.99K8.87K103.20K67.42K39.26K29.43K651.12K165.72K63.44K719.92K611.19K191.00K35.75M32.68M149.06M107.99M10.91M27.55M68.32M23.64M16.45M18.51M16.95M34.32M
Free Cash Flow-3.17M-1.79M-3.25M-1.91M-4.00M-5.53M-10.55M-8.36M-5.04M710.56K-16.19M-18.60M-40.16M-48.59M-25.89M-5.67M-13.72M-15.42M-121.59M-68.57M56.16M18.08M-53.05M-20.32M-47.66M100.45M47.06M150.90M
Dividends Paid-------------0000000190.00K5.74M618.00K190.00K1.63M1.63M1.63M1.16M
FCF to OCF104.11%100.24%101.35%104.76%100.98%100.16%100.99%100.81%100.79%96.02%104.19%100.90%100.16%101.50%102.42%103.48%-62.27%-89.31%-442.59%-173.96%83.73%39.63%-347.51%-611.56%152.74%84.44%73.52%81.47%
Dividend Paid to FCF-------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.34%31.73%-1.16%-0.94%-3.41%1.62%3.45%0.77%

Earnings

Report DateSep 30, 2001Dec 31, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Dec 31, 2002May 15, 2003Aug 16, 2003Nov 12, 2003Mar 9, 2004May 17, 2004Aug 16, 2004Nov 12, 2004Feb 15, 2005May 13, 2005Aug 12, 2005Nov 10, 2005Mar 31, 2006May 12, 2006Aug 14, 2006Nov 14, 2006Mar 8, 2007May 1, 2007Aug 14, 2007Nov 13, 2007Mar 17, 2008May 9, 2008Aug 11, 2008Nov 10, 2008Mar 16, 2009May 11, 2009Aug 7, 2009Nov 9, 2009Mar 30, 2010May 14, 2010Aug 12, 2010Nov 12, 2010Mar 16, 2011May 10, 2011Jul 25, 2011Nov 9, 2011Mar 13, 2012May 8, 2012Aug 1, 2012Nov 8, 2012Mar 1, 2013May 13, 2013Aug 9, 2013Nov 4, 2013Feb 18, 2014May 5, 2014Aug 4, 2014Nov 3, 2014Feb 19, 2015May 5, 2015Aug 4, 2015Nov 3, 2015Feb 23, 2016May 5, 2016Aug 4, 2016Nov 3, 2016Mar 2, 2017May 4, 2017Aug 3, 2017Nov 2, 2017Feb 27, 2018May 8, 2018Aug 7, 2018Nov 6, 2018Feb 27, 2019May 9, 2019Aug 7, 2019Nov 6, 2019Feb 27, 2020May 7, 2020Aug 6, 2020Nov 5, 2020Mar 9, 2021May 7, 2021Aug 6, 2021Nov 1, 2021Mar 15, 2022May 10, 2022Aug 8, 2022Nov 9, 2022Mar 9, 2023May 8, 2023Aug 9, 2023Nov 8, 2023Feb 29, 2024May 10, 2024Aug 6, 2024Nov 8, 2024Feb 26, 2025May 9, 2025Aug 8, 2025Nov 7, 2025Feb 26, 2026May 8, 2026Aug 7, 2026Nov 6, 2026
EPS Estimate-----------4.32--5.76-6.30-5.22-5.40-4.86-4.41-6.48-5.22-4.14-2.88-2.88-3.24-3.69-2.88-3.60-5.76-7.20-8.64-5.76-5.40-5.76-3.96-3.78-3.78-5.04-5.31-5.18-6.48-5.10-4.05-1.98-2.46-1.80---0.320.240.340.080.460.590.530.550.550.600.700.771.081.090.790.860.991.071.271.341.171.241.051.291.431.180.890.750.880.940.710.610.700.740.090.220.550.670.350.670.840.861.000.951.090.291.381.421.772.040.961.671.77
EPS Actual1.87-7.84-5.85-7.93-3.91-1.97-4.96-6.41-4.31-5.41-6.12-5.55-5.76-7.92-5.04-4.68-3.60-4.68-6.12-3.96-1.0815.84-2.88-3.60-2.16-2.16-4.68-7.92-8.64-1.80-5.40-6.12-7.56-31.32-6.84-6.12-5.76-6.48-7.20-5.76-4.32-2.16-3.24-2.16-1.62-1.10-0.56-36.120.360.410.33-0.040.660.420.570.550.630.520.761.111.090.840.740.981.111.081.321.131.291.321.301.441.231.081.040.690.970.801.040.671.010.54-0.120.130.640.761.171.281.271.001.211.021.34-0.551.701.802.042.331.681.82-
Surprise-----------41.67%-0.00%-25.71%3.45%13.33%25.93%-6.12%5.56%24.14%73.91%650.00%0.00%-11.11%41.46%25.00%-30.00%-37.50%-20.00%79.17%6.25%-13.33%-31.25%-690.91%-80.95%-61.90%-14.29%-22.03%-39.00%11.11%15.29%46.67%-63.64%12.20%10.00%---12.50%70.83%-2.94%-150.00%43.48%-28.81%7.55%0.00%14.55%-13.33%8.57%44.16%0.93%-22.94%-6.33%13.95%12.12%0.93%3.94%-15.67%10.26%6.45%23.81%11.63%-13.99%-8.47%16.85%-8.00%10.23%-14.89%46.48%9.84%44.29%-27.03%-233.33%-40.91%16.36%13.43%234.29%91.04%51.19%16.28%21.00%7.37%22.94%-287.52%23.19%26.76%15.25%14.22%75.00%8.98%-
Timing--------------------------------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap1.70B
Enterprise Value1.94B
Trailing P/E16.19
Forward P/E7.12
PEG Ratio1.06
Price / Sales1.74
Price / Book2.86
EPS4.57
Book Value27.87
Revenue (TTM)978.38M
Gross Profit (TTM)590.98M
EBITDA209.41M
Profit Margin11.07%
Operating Margin14.97%
Return on Equity20.46%
Return on Assets5.45%
Shares Outstanding22.96M
Shares Float19.66M
Beta0.45
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 6 analystsTarget 105.78
  • Strong Buy
    3
  • Buy
    2
  • Hold
    1

Ownership Breakdown

Institutions
107.07%
Insiders
5.42%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    2.75M11.96%
  • Soleus Capital Management, L.P.
    867.76K3.78%
  • Vanguard Capital Management, LLC
    823.06K3.58%
  • State Street Corp
    771.59K3.36%
  • TANG CAPITAL MANAGEMENT LLC
    707.50K3.08%
  • Dimensional Fund Advisors, Inc.
    623.46K2.71%
  • American Century Companies Inc
    574.47K2.50%
  • Arrowstreet Capital Limited Partnership
    564.36K2.46%
  • Global Alpha Capital Management Ltd.
    558.00K2.43%
  • Millennium Management LLC
    507.21K2.21%
  • UBS Group AG
    497.70K2.17%
  • Geode Capital Management, LLC
    489.20K2.13%
  • Nuveen, LLC
    402.36K1.75%
  • Vanguard Portfolio Management, LLC
    375.96K1.64%
  • Ranger Investment Management LP
    343.15K1.49%
  • Amvescap Plc.
    324.35K1.41%

Top Fund Holders

  • iShares Core S&P Small-Cap ETF
    1.11M4.84%
  • Avantis US Small Cap Value ETF
    645.69K2.81%
  • Vanguard MStar Total Stk Mkt Idx Invest
    614.62K2.68%
  • iShares Russell 2000 ETF
    519.52K2.26%

Stock Splits

  • Jul 18, 20131:6
  • Jun 4, 20121:6
  • Jun 3, 20021:10